Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab

Josée Golay, PhD, Fabio Da Roit, BSc, Luca Bologna, BSc, Claudia Ferrara Koller, PhD, Jeanette H. W. Leusen, PhD, Alessandro Rambaldi, MD, Christian Klein, PhD, Martino Introna, MD

Blood (2013) 122 (21): 4419.

https://doi.org/10.1182/blood.V122.21.4419.4419

Published: 2013

Journal Articles

Massive, Clinical Grade Expansion Of Polyclonal T Cells Using Blinatumomab For Adoptive Autologous Cellular Therapy Of CLL Patients

Josée Golay, PhD, Anna D’amico, PhD, Gianmaria Borleri, Maria Chiara Finazzi, MD, Giulia Quaresmini, MD, Martino Introna, MD, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 3272.

https://doi.org/10.1182/blood.V122.21.3272.3272

Published: 2013

Journal Articles

Hematopoietic Progenitor Cells From Patients with Chronic Mountain Sickness Lack the JAK2 V617F Mutation, Show Hypersensitivity to Erythropoietin and Are Inhibited by Statins.

Ricardo Amaru, MD, Martin Villarroel, MD, Hortencia Miguez, BSc, Rosario Peñaloza, BSc, Gina Torres, BSc, Tiziano Barbui, MD, Josee Golay, PhD, Alessandro Rambaldi, MD

Blood (2009) 114 (22): 1894.

https://doi.org/10.1182/blood.V114.22.1894.1894

Published: 2009

Journal Articles

IL-10 Present in the B Lymphoma Microenvironment Drives Macrophages to Efficient Tumour Suppressing Cells with High Phagocytic Activity in Presence of Rituximab.

Josee Golay, PhD, Marzia Leidi, Elisa Gotti, Giuseppe Palumbo, Martino Introna, MD

Blood (2008) 112 (11): 1582.

https://doi.org/10.1182/blood.V112.11.1582.1582

Published: 2008

Journal Articles

Human Macrophages Phagocytose Rituximab Opsonised Leukemic Cells Via CD16, CD32 and CD64 but Do Not Mediate ADCC.

Josee Golay, PhD, Marzia Leidi, BSc, Giuseppe A. Palumbo, MD, Martino Introna, MD

Blood (2006) 108 (11): 2507.

https://doi.org/10.1182/blood.V108.11.2507.2507

Published: 2006

Journal Articles

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Martino Introna, MD, Gianmaria Borleri, Elena Conti, Anna M. Barbui, MD, Raewyn Broady, BSc, Erica Dander, BSc, Giuseppe Gaipa, BSc, Giovanna D’Amico, BSc, Ettore Biagi, MD, Matteo Parma, MD, Enrico Pogliani, MD, Orietta Spinelli, BSc, Donatella Baronciani, MD, Anna Grassi, MD, Josee Golay, PhD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3698.

https://doi.org/10.1182/blood.V108.11.3698.3698

Published: 2006

Journal Articles

Rapid and Massive Expansion of Cord Blood Derived Cytokine Induced Killer (CIK) Cells: An Innovative Proposal for the Treatment of Leukemia Relapse after Cord Blood Transplantation.

Martino Introna, MD, Marta Franceschetti, BSc, Alice Ciocca, BSc, Gianmaria Borleri, Elena Conti, Josee Golay, PhD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 723.

https://doi.org/10.1182/blood.V108.11.723.723

Published: 2006

Journal Articles

Potent Cytotoxicity Against Multiple Myeloma and Acute Myeloid Leukemia Cells by a New Histone Deacetylase Inhibitor ITF2357.

Alessandro Rambaldi, MD, Caterina Micò, Lucia Cuppini, Marcello Domenghini, Gian Maria Borleri, Anna Maria Barbui, MD, Flavio Leoni, Paolo Mascagni, MD, Anna Salvi, Josee Golay, PhD, Martino Introna, MD

Blood (2005) 106 (11): 3361.

https://doi.org/10.1182/blood.V106.11.3361.3361

Published: 2005

Journal Articles

Acute Lymphoblastic Leukaemia Cells Carrying the t(12;21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis.

Josee Golay, PhD, Chiara Cortiana, Giovanni Cazzaniga, Anna Salvi, Massimiliano Manganini, Orietta Spinelli, Renato Bassan, MD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD, Martino Introna, MD

Blood (2005) 106 (11): 872.

https://doi.org/10.1182/blood.V106.11.872.872

Published: 2005

NARROW

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab

Massive, Clinical Grade Expansion Of Polyclonal T Cells Using Blinatumomab For Adoptive Autologous Cellular Therapy Of CLL Patients

Hematopoietic Progenitor Cells From Patients with Chronic Mountain Sickness Lack the JAK2 V617F Mutation, Show Hypersensitivity to Erythropoietin and Are Inhibited by Statins.

IL-10 Present in the B Lymphoma Microenvironment Drives Macrophages to Efficient Tumour Suppressing Cells with High Phagocytic Activity in Presence of Rituximab.

Human Macrophages Phagocytose Rituximab Opsonised Leukemic Cells Via CD16, CD32 and CD64 but Do Not Mediate ADCC.

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Rapid and Massive Expansion of Cord Blood Derived Cytokine Induced Killer (CIK) Cells: An Innovative Proposal for the Treatment of Leukemia Relapse after Cord Blood Transplantation.

Potent Cytotoxicity Against Multiple Myeloma and Acute Myeloid Leukemia Cells by a New Histone Deacetylase Inhibitor ITF2357.

Acute Lymphoblastic Leukaemia Cells Carrying the t(12;21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only